MedTrace Logo

Home Treatment for Acute Psychiatric Care

NCT02322437 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 707

Last updated 2018-06-06

No results posted yet for this study

Summary

This study aims to evaluate whether psychiatric home treatment is an effective and efficient alternative to acute inpatient care in mental hospitals. A one-year prevalence cohort of psychiatric patients in need of hospitalization are randomly assigned to either treatment at inpatient wards (treatment as usual) or a new care model with the additional option of treating patients at their homes by mobile care teams. The primary focus is on checking whether optional home treatment leads to a reduction of inpatient days during a two-year follow-up period. In addition, the two service models will be compared regarding treatment cost and outcomes as well as satisfaction of patients and their relatives with psychiatric care.

Furthermore, a sub-cohort of randomly chosen patients from the prevalence-cohort will be examined by a highly trained clinical assessor to test and verify the diagnoses and the clinical ratings made by the staff members of the mental hospital under routine everyday conditions.

Conditions

  • Mental Disorders

Interventions

OTHER

Home treatment

Patients are treated at home whenever possible and appropriate

OTHER

Treatment As Usual

Patients are treated at a mental hospital

Sponsors & Collaborators

  • Hugo & Elsa Isler Foundation

    collaborator UNKNOWN

  • Psychiatric Services Aargau AG

    lead OTHER

Principal Investigators

  • Niklaus Stulz, PhD · Psychiatric Services Aargau AG

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2018-04-30
Completion
2018-04-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02322437 on ClinicalTrials.gov